维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Ruslami R"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes显示文摘	Nijland HM Ruslami R Stalenhoef JE	2006	Clin Infect Dis2006，43，7：	1
2	Implications of the global increase of diabetes for tuberculosls control and patient care显示文摘	Ruslami R Aarnoutse RE Alisjahbana B	2010	Trop Med Int Health2010，15，11：	1
3	Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial显示文摘	Ruslami R Ganiem A R Dian S	2013	Lancet Infect Dis2013，13，1：	1
4	Pharmacokinetics of an- tituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes显示文摘	Ruslami R Nijland HM Adhiarta IG	2010	Antimicrob Agents Chemother2010，54，：	1
5	Isoniazid,rifampin,and pyrazinamide plasma concentrations in relation to treatment response in Indonesian pulmonary tuberculosis patients显示文摘	Burhan E Ruesen C Ruslami R	2013	Antimicrob Agents Chemother2013，57，8：	1
6	Exposure to rifampiein is strongly reduced in patients with tuberculosis and type 2 diabetes 显示文摘	Nijland HM Ruslami R Stalenhoef JE	2006	Clin Infect Dis2006，43，7：	1
7	Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial 显示文摘	Ruslami R Ganiem AR Dian S	2013	Lancet Infect Dis2013，13，1：	1
8	Pharmacokinet- ics and tolerability of a higher rifampin dose versus the stan- dard dose in pulmonary tuberculosis patients显示文摘	Ruslami R Nijland HM Alisjahbana B	2007	Antimirob A- gents Chemother2007，51，7：	1
9	Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes显示文摘	Nijland HM Ruslami R Stalenhoef JE	2006	Clin Infect Dis2006，43，7：	1
10	Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes显示文摘	Nijland HM Ruslami R Stalenhoef JE	2006	Clin Infect Dis2006，43，7：	1
11	Implications of the global increase of diabetes for tuberculosis control and patient care 显示文摘	Ruslami R Aarnoutse RE Alisjahbana B	2010	Trop Med Int Health2010，15，11：	1
12	Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes显示文摘	Nijland HM Ruslami R Stalenhoef JE	2006	Clin Infect Dis2006，43，7：	1
13	Intensified regimen containing rifampicin and moxiiloxacin for tuberculous meningitis:an open-label,randomised controlled phase 2 trial显示文摘	Ruslami R Ganiem AR Dian S	2013	Lancet Infect Dis2013，13，1：	1
14	Exposure to rifam- picin is strongly reduced in patients with tuberculosis and type 2 diabetes 显示文摘	Nijland HM Ruslami R Stalenhoef JE	2006	Clin Infect Dis2006，43，7：	1
15	Exposure to rifampicin is strongly reduced in patients with tuberculosis and type 2 diabetes显示文摘	Nijland HM Ruslami R Stalenhoef JE	2006	Clin Infect Dis2006，43，7：	1
16	Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis:an open-label,randomized controlled phase 2 trial显示文摘	Ruslami R Ganiem AR Dian S	2013	Lancet Infect Dis2013，13，1：	1
17	Intensified regimen contain- ing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial显示文摘	Ruslami R Ganiem A R Dian S	2013	Lancet Infect Dis2013，13，1：	1
18	Pharmaeokineties of antituberculosis drugs in pulmonary tuberculosis patients with type 2 diabetes 显示文摘	Ruslami R Niliand HM Adhiarta IG	2010	Antimicrob Agents Chemother2010，54，3：	1
19	Rit'ampicin re- duces plasma concentrations of moxifloxacin in patients with tuberculosis显示文摘	Nijland H M J Ruslami R Suroto A J	2007	Clin Infec Dis2007，，：	1
20	Implica- tions of the global increase of diabetes for tuberculosis con- trol and patient care 显示文摘	Ruslami R Aarnoutse RE Alisjahbana B	2010	Trop Med Int Health2010，15，11：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示